Chemotherapy of experimental transitional-cell carcinoma
β Scribed by Jean B. Dekernion; Mark S. Soloway; Lester Persky
- Book ID
- 119042456
- Publisher
- Elsevier Science
- Year
- 1974
- Tongue
- English
- Weight
- 687 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Activity has been demonstrated for both single agents and combination chemotherapy in advanced transitional cell carcinoma of the uroepithelium. Regimens are palliative; duration of response has been modest, usually ranging from 3 to 8 months. There are few complete responders; occasional patients r
Although the incidence of bladder cancer has increased in recent years, survival has also improved. Chemotherapy has made a substantial impact on this disease and now is used in patients with advanced or metastatic disease as well as in select patients with high-risk muscle invasive disease. While c